investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Fraser Symmans

1 Collaborator(s)

Funding source

University of Texas MD Anderson Cancer Center

No posts

Related projects

James K Turkson

Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy

Breast

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Breast

Joyce M Slingerland

Effects of the PI3K Pathway on p27 Function and Cancer Progression

Breast

Dipak Panigrahy

Control of Cancer and Metastasis by Endothelial-Derived Epoxyeicosatrienoic Acids

Breast

Agata Smogorzewska

The role of nucleases in interstrand crosslink repair

Breast

William J Murphy

1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer

Breast

Maria Jasin

HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES

Breast

Lauren E Burkard

Mechanisms of Macrophage-Mediated Tumor Metastasis

Breast

Elizabeth Mittendorf

Immunologic Aspects of Triple Negative Breast Cancer and the Effects of Neoadjuvant Systemic Therapy

Breast